LAUREN ALLEN: Open Payments
NPI 1124714274 · LEESBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$506 in 26 payments from 10 companies in 2025. Trend: 2023 $56 · 2024 $314 · 2025 $506
Food & beverage: $506
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $88 |
| Amgen Inc. | 3 | $70 |
| Lundbeck LLC | 3 | $66 |
| Eisai Inc. | 3 | $65 |
| Neurelis, Inc. | 3 | $52 |
| PFIZER INC. | 3 | $52 |
| ARGENX US, INC. | 3 | $42 |
| Biogen, Inc. | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| UCB, Inc. | 1 | $19 |
Products named: UPLIZNA, VYEPTI, Leqembi, QULIPTA, VALTOCO, VYVGART HYTRULO, TYSABRI, UBRELVY.
Industry payments across VA — which companies pay providers there.
